Steward Partners Investment Advisory’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52 | Sell |
2
-1
| -33% | -$26 | ﹤0.01% | 4062 |
|
|
2025
Q1 | $27 | Hold |
3
| – | – | ﹤0.01% | 3981 |
|
|
2024
Q4 | $37 | Hold |
3
| – | – | ﹤0.01% | 3938 |
|
|
2024
Q3 | $52 | Hold |
3
| – | – | ﹤0.01% | 3689 |
|
|
2024
Q2 | $50 | Sell |
3
-10
| -77% | -$167 | ﹤0.01% | 3572 |
|
|
2024
Q1 | $187 | Hold |
13
| – | – | ﹤0.01% | 3476 |
|
|
2023
Q4 | $113 | Hold |
13
| – | – | ﹤0.01% | 3435 |
|
|
2023
Q3 | $119 | Hold |
13
| – | – | ﹤0.01% | 3316 |
|
|
2023
Q2 | $115 | Hold |
13
| – | – | ﹤0.01% | 3263 |
|
|
2023
Q1 | $141 | Hold |
13
| – | – | ﹤0.01% | 3243 |
|
|
2022
Q4 | $452 | Hold |
13
| – | – | ﹤0.01% | 3205 |
|
|
2022
Q3 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 3143 |
|
|
2022
Q2 | – | Sell |
-129
| Closed | -$10K | – | 3325 |
|
|
2022
Q1 | $10K | Hold |
129
| – | – | ﹤0.01% | 2667 |
|
|
2021
Q4 | $26K | Hold |
129
| – | – | ﹤0.01% | 2214 |
|
|
2021
Q3 | $35K | Sell |
129
-33
| -20% | -$8.95K | ﹤0.01% | 2054 |
|
|
2021
Q2 | $42K | Buy |
+162
| New | +$42K | ﹤0.01% | 3685 |
|
|
2020
Q1 | – | Sell |
-40
| Closed | -$12K | – | 2629 |
|
|
2019
Q4 | $12K | Hold |
40
| – | – | ﹤0.01% | 1955 |
|
|
2019
Q3 | $10K | Buy |
+40
| New | +$10K | ﹤0.01% | 1995 |
|